Results 51 to 60 of about 14,229 (206)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile

Gastroenterology Insights, 2023
Hepatorenal syndrome stands as one of several potential triggers of acute kidney injury in individuals grappling with either acute or persistent liver ailments. The nature of the decline in kidney function has led to the identification of two variants of
Ahlam Ayyad, Rami A. Al-Horani
doaj   +1 more source

Microbubble‐Based Ultrasound Contrast Agents in Contrast‐Enhanced Ultrasonography for Managing Portal Hypertension in Cirrhosis

Portal Hypertension &Cirrhosis, EarlyView.
As the hepatic venous pressure gradient (HVPG) remains the current gold standard for diagnosing portal hypertension in cirrhosis, its clinical application is limited by invasiveness, high cost, and restricted availability. Given the urgent need for noninvasive techniques to dynamically monitor portal vein pressure (PVP), contrast‐enhanced ...
Danping Huang, Zefeng Liu, Lingling Liu, Fen Huang, Wenjuan Wang, Guo Zhang   +5 more
wiley   +1 more source

The Hepatorenal Syndrome (HRS)

, 1987
Progressive oliguric renal failure commonly complicates the course of patients with advanced hepatic disease (1,2). While this condition has been designated by many names including “functional renal failure”, and “the renal failure of cirrhosis”, the ...
Murray Epstein, Epstein, Murray
core   +1 more source

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)

Gastroenterologìa
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease.
M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko   +4 more
doaj   +1 more source

Potentially Preventable Mortality After Elective Colorectal Cancer Surgery: Insights From a National Surgical Mortality Audit

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Colorectal cancer (CRC) is a significant contributor to preventable deaths worldwide. The assessment of potentially avoidable mortality following elective CRC surgery has yet to be reported. The Australian and New Zealand Audit of Surgical Mortality (ANZASM) seeks to peer‐review all deaths associated with surgical care.
Sergei Bedrikovetski, Luke Traeger, Nathan Procter, Helena S. Kopunic, Guy J. Maddern   +4 more
wiley   +1 more source

Terlipressin for hepatorenal syndrome

, 2012
Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is ...
Kurt Christensen, Christensen, Kurt, Aleksander Krag, Gluud, Lise Lotte, Lise Lotte Gluud, Erik Christensen, Christensen, Erik, Krag, Aleksander   +7 more
core   +1 more source

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME

Вестник трансплантологии и искусственных органов, 2009
34 patients (23 male, 11 female) in the age of 41–77 years (mean age 59,7 ± 4,2 years) with 2 type hepatorenal syndrome were included in the study. All patients were divided in 3 groups.
D. E. Kutepov, I. N. Pasechnik, N. P. Mironov, E. V. Tsygankov, A. V. Popov, O. K. Morochova, S. V. Stebletsov, E. Y. Kotselapova, M. G. Vershinina   +8 more
doaj   +1 more source

Role of human albumin in the management of liver cirrhosis

Медицинский совет, 2020
Aim. To demonstrate the role of concentrated human albumin in cirrhotic patient management.The main content. Albumin has a clear place in the clinical practice of cirrhotic patients managing.
M. V. Maevskaya, M. S. Zharkova
doaj   +1 more source

Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory‐Wide Cohort Study

Alimentary Pharmacology &Therapeutics, EarlyView.
In this territory‐wide cohort study, improving glycemic control can be observed regardless of cirrhosis status. Oral antidiabetic medication was more often used in the non‐cirrhosis group, and insulin was preferred in patients with decompensated cirrhosis, who exhibited an increasing incidence of hypoglycemia over the years and need individualized ...
Mary Yue Wang, Sherlot Juan Song, Nana Peng, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Jimmy Che‐To Lai, Terry Cheuk‐Fung Yip   +6 more
wiley   +1 more source

Syndrome Hépatorénal : Aspects Epidémiologiques, Diagnostiques et Pronostiques

Health Research in Africa
RÉSUMÉ Introduction. Le syndrome Hépatorénal (SHR) est une forme particulière d’insuffisance rénale aigue fonctionnelle qui survient chez le patient atteint de cirrhose décompensée. Le traitement curatif reste la transplantation hépatique.
Ousseini F, Bonkano D, Hamidine I, Abdou B, Nayama M, Ali cheik R, Abdou N, Abdou Djibo B, Lawagoulé Joseph Emile KY, Sani K, Daou M   +10 more
doaj   +1 more source